MDA Opens Registration for 2027 Conference Amid Accelerated Neuromuscular Research
Event summary
- Registration opens for the 2027 MDA Clinical & Scientific Conference, scheduled for March 21–24 in Orlando.
- Conference highlights advances in neuromuscular research, including AI-driven drug discovery and gene therapies.
- Abstract submission deadline set for December 14, 2026, with late-breaking submissions accepted until February 18, 2027.
- MDA supports over 130 active research grants, integrating global research with clinical care networks.
The big picture
The MDA conference underscores the rapid advancements in neuromuscular disease research, driven by AI, precision medicine, and collaborative networks. The event serves as a critical platform for translating scientific breakthroughs into clinical applications, reflecting broader industry trends toward faster therapeutic development cycles.
What we're watching
- AI Integration
- How AI-enabled drug discovery will accelerate the development of therapies for neuromuscular diseases.
- Clinical Translation
- The pace at which scientific discoveries transition from laboratory research to patient treatments.
- Advocacy Impact
- Whether collaborative advocacy efforts will enhance access to treatments and caregiver support.
Related topics